2007

• Agarwal AK, Sukumaran S, Bartz R, Barnes RI, Garg A.
  Functional characterization of human 1-acylglycerol-3-phosphate-O-acyltransferase isoform 9: cloning, tissue distribution, gene structure, and enzymatic activity.
  J Endocrinol. 2007 Jun;193(3):445-57.
• Pan Y, Garg A, Agarwal AK.
  Mislocalization of prelamin A Tyr646Phe mutant to the nuclear pore complex in human embryonic kidney 293 cells.
  Biochem Biophys Res Commun. 2007 Mar 30;355(1):78-84. Epub 2007 Jan 31.
• Sherbet DP, Papari-Zareei M, Khan N, Sharma KK, Brandmaier A, Rambally S, Chattopadhyay A, Andersson S, Agarwal AK, Auchus RJ.
  Cofactors, redox state, and directional preferences of hydroxysteroid dehydrogenases.
  Mol Cell Endocrinol. 2007 Feb;265-266:83-8. Epub 2007 Jan 12.
  

2006

• Denecke J, Brune T, Feldhaus T, Robenek H, Kranz C, Auchus RJ, Agarwal AK, Marquardt T.
  A homozygous ZMPSTE24 null mutation in combination with a heterozygous mutation in the LMNA gene causes Hutchinson-Gilford progeria syndrome (HGPS): insights into the pathophysiology of HGPS.
  Hum Mutat. 2006 Jun;27(6):524-31.
• Agarwal AK, Garg A.
  Genetic Disorders of Adipose Tissue Development, Differentiation, and Death.
  Annu Rev Genomics Hum Genet. 2006 May 24; [Epub ahead of print]
• Agarwal AK, Barnes RI, Garg A.
  Functional characterization of human 1-acylglycerol-3-phosphate acyltransferase isoform 8: Cloning, tissue distribution, gene structure, and enzymatic activity.
  Arch Biochem Biophys. 2006 May 15;449(1-2):64-76. Epub 2006 Mar 29.
• Agarwal AK, Garg A.
  Genetic basis of lipodystrophies and management of metabolic complications.
  Annu Rev Med. 2006;57:297-311. Review. 

2005

• Jacob KN, Baptista F, dos Santos HG, Oshima J, Agarwal AK, Garg A.
  Phenotypic heterogeneity in body fat distribution in patients with atypical Werner's syndrome due to heterozygous Arg133Leu lamin A/C mutation.
  J Clin Endocrinol Metab. 2005 Dec;90(12):6699-706. Epub 2005 Sep 20. 
• Haque W, Garg A, Agarwal AK.
  Enzymatic activity of naturally occurring 1-acylglycerol-3-phosphate-O-acyltransferase 2 mutants associated with congenital generalized lipodystrophy.
  Biochem Biophys Res Commun. 2005 Feb 11;327(2):446-53. 
• Agarwal AK, Auchus RJ. 
  Minireview: cellular redox state regulates hydroxysteroid dehydrogenase activity and intracellular hormone potency.
  Endocrinology. 2005 Jun;146(6):2531-8. Epub 2005 Mar 17. Review. 
• Shackleton S, Smallwood DT, Clayton P, Wilson LC, Agarwal AK, Garg A, Trembath RC. 
  Compound heterozygous ZMPSTE24 mutations reduce prelamin A processing and result in a severe progeroid phenotype.
  J Med Genet. 2005 Jun;42(6):e36. No abstract available. 
• Garg A, Cogulu O, Ozkinay F, Onay H, Agarwal AK.  
  A novel homozygous Ala529Val LMNA mutation in Turkish patients with mandibuloacral dysplasia.
  J Clin Endocrinol Metab. 2005 Sep;90(9):5259-64. Epub 2005 Jul 5. Review. 

2004

• Duplomb L, Lee Y, Wang MY, Park BH, Takaishi K, Agarwal AK, Unger RH. 
  Increased expression and activity of 11beta-HSD-1 in diabetic islets and prevention with troglitazone.
  Biochem Biophys Res Commun. 2004 Jan 16;313(3):594-9. 
• Agarwal AK, Barnes RI, Garg A. 
  Genetic basis of congenital generalized lipodystrophy.
  Int J Obes Relat Metab Disord. 2004 Feb;28(2):336-9. Review. 
• Agarwal AK, Garg A. 
  Seipin: a mysterious protein.
  Trends Mol Med. 2004 Sep;10(9):440-4. Review. No abstract available.

2003

• Simha V, Agarwal AK, Oral EA, Fryns JP, Garg A. 
  Genetic and phenotypic heterogeneity in patients with mandibuloacral dysplasia-associated lipodystrophy.
  J Clin Endocrinol Metab. 2003 Jun;88(6):2821-4. 
• Agarwal AK, Fryns JP, Auchus RJ, Garg A. 
  Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia.
  Hum Mol Genet. 2003 Aug 15;12(16):1995-2001. 
• Haque WA, Oral EA, Dietz K, Bowcock AM, Agarwal AK, Garg A.
  Risk factors for diabetes in familial partial lipodystrophy, Dunnigan variety.
  Diabetes Care. 2003 May;26(5):1350-5. 
• Agarwal AK, Simha V, Oral EA, Moran SA, Gorden P, O'Rahilly S, Zaidi Z, Gurakan F, Arslanian SA, Klar A, Ricker A, White NH, Bindl L, Herbst K, Kennel K, Patel SB, Al-Gazali L, Garg A. 
  Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy.
  J Clin Endocrinol Metab. 2003 Oct;88(10):4840-7. 
• Agarwal AK. 
  Cortisol metabolism and visceral obesity: role of 11beta-hydroxysteroid dehydrogenase type I enzyme and reduced co-factor NADPH.
  Endocr Res. 2003 Nov;29(4):411-8. Review. 
• Agarwal AK, Garg A.
  Molecular basis of congenital generalized lipodystrophy: significance of triglyceride biosynthetic pathways.
  Trends Endocrinol Metab 14:214-221, 2003.

2002

• Agarwal AK, Arioglu E, De Almeida S, Akkoc N, Taylor SI, Bowcock AM, Barnes RI, Garg A.
  AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34.
  Nat Genet. 2002 May;31(1):21-3. Epub 2002 Apr 22. 
• Agarwal AK, Garg A.
  A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy.
  J Clin Endocrinol Metab. 2002 Jan;87(1):408-11. 

2001

• Agarwal AK.
  Transcriptional influence of two poly purine-pyrimidine tracts located in the HSD11B2 (11beta-hydroxysteroid dehydrogenase type 2) gene.
  Endocr Res. 2001 Feb-May;27(1-2):1-9. 
• White PC, Agarwal AK, Li A, Nikkila H, Pratt JH, Caulfield M, Clark A, McTernan C, Stewart PM.
  Possible association but no linkage of the HSD11B2 gene encoding the kidney isozyme of 11beta-hydroxysteroid dehydrogenase to hypertension in Black people.
  Clin Endocrinol (Oxf). 2001 Aug;55(2):249-52. 

2000

• Agarwal AK, Giacchetti G, Lavery G, Nikkila H, Palermo M, Ricketts M, McTernan C, Bianchi G, Manunta P, Strazzullo P, Mantero F, White PC, Stewart PM. 
  CA-Repeat polymorphism in intron 1 of HSD11B2 : effects on gene expression and salt sensitivity.
  Hypertension. 2000 Aug;36(2):187-94. 
• Agarwal AK. 
  Expression of HSD11K (NAD dependent 11beta-hydroxysteroid dehydrogenase) promoter constructs in renal cell lines.
  Endocr Res. 2000 May;26(2):289-302. 
• Agarwal AK, White PC. 
  Structure of the VPATPD gene encoding subunit D of the human vacuolar proton ATPase.
  Biochem Biophys Res Commun. 2000 Dec 20;279(2):543-7. 
• White PC, Agarwal AK, Nunez BS, Giacchetti G, Mantero F and Stewart PM.
  Genotype-phenotype correlations of mutations and polymorphisms in HSD11B2, the gene encoding the kidney isozyme of 11beta-hydroxysteroid dehydrogenase.
  Endocrine Research 2000; 26: 771-80.

1997

• White PC, Mune T, Rogerson FM, Kayes KM, Agarwal AK. 
  Molecular analysis of 11 beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.
  Steroids. 1997 Jan;62(1):83-8. Review. 
• White PC, Mune T, Agarwal AK.
  11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess.
  Endocr Rev. 1997 Feb;18(1):135-56. Review.

• Agarwal AK, White PC. 
  Analysis of the promoter of the NAD dependent 11 beta-hydroxysteroid dehydrogenase (HSD11K) gene in JEG-3 human choriocarcinoma cells.
  Mol Cell Endocrinol. 1996 Jul 23;121(1):93-9. Erratum in: Mol Cell Endocrinol 1997 May 16;129(2):241-2. 

1995

• Agarwal AK, Mune T, Monder C, White PC.
  Cloning of cDNA encoding an NAD( )-dependent isoform of 11 beta-hydroxysteroid dehydrogenase in sheep kidney.
  Endocr Res. 1995 Feb-May;21(1-2):389-97. 
• White PC, Mune T, Agarwal AK. 
  Functional studies of 11 beta-hydroxysteroid dehydrogenase.
  Steroids. 1995 Jan;60(1):65-8. Review. 
• Agarwal AK, Mune T, Monder C, White PC. 
  Mutations in putative glycosylation sites of rat 11 beta-hydroxysteroid dehydrogenase affect enzymatic activity.
  Biochim Biophys Acta. 1995 Apr 5;1248(1):70-4. 
• Agarwal AK, Rogerson FM, Mune T, White PC. 
  Analysis of the human gene encoding the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase.
  J Steroid Biochem Mol Biol. 1995 Dec;55(5-6):473-9. 
• Mune T, Rogerson FM, Nikkila H, Agarwal AK, White PC.
  Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase.
  Nat Genet. 1995 Aug;10(4):394-9. 
• Agarwal AK, Rogerson FM, Mune T, White PC.
  Gene structure and chromosomal localization of the human HSD11K gene encoding the kidney (type 2) isozyme of 11 beta-hydroxysteroid dehydrogenase.
  Genomics. 1995 Sep 1;29(1):195-9. 

1994

• Agarwal AK, Mune T, Monder C, White PC.
  NAD( )-dependent isoform of 11 beta-hydroxysteroid dehydrogenase. Cloning and characterization of cDNA from sheep kidney.
  J Biol Chem. 1994 Oct 21;269(42):25959-62. 
• White PC, Obeid J, Agarwal AK, Tannin GM, Nikkila H.
  Genetic analysis of 11 beta-hydroxysteroid dehydrogenase.
  Steroids. 1994 Feb;59(2):111-5. Review. 

1991

• Agarwal AK, Bindal RD.
  Estrogen receptor-binding affinity of tamoxifen analogs with various side chains and their biologic profile in immature rat uterus.
  Steroids. 1991 Sep;56(9):486-9. 
• Tannin GM, Agarwal AK, Monder C, New MI, White PC.
  The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization.
  J Biol Chem. 1991 Sep 5;266(25):16653-8. 

1990

• Agarwal AK, Tusie-Luna MT, Monder C, White PC.
  Expression of 11 beta-hydroxysteroid dehydrogenase using recombinant vaccinia virus.
  Mol Endocrinol. 1990 Dec;4(12):1827-32. 
• Moisan M-P, Seckl  JR, Brett LP, Monder C, Agarwal AK, White PC, Edwards CRW.
  11ß-Hydroxysteroid dehydrogenase messanger ribonucleic acid expression,  bioactivity and immunoreactivity in rat cerebellum. 
  J Neuroendocrinol 1990; 2:853-858.

1989

• Agarwal AK, Monder C.
  In vitro metabolism of 7 alpha-methyl-19-nortestosterone by rat liver, prostate, and epididymis.
  Endocrinology. 1988 Nov;123(5):2187-93. 
• Agarwal AK, Monder C, Eckstein B, White PC.
  Cloning and expression of rat cDNA encoding corticosteroid 11 beta-dehydrogenase.
  J Biol Chem. 1989 Nov 15;264(32):18939-43.   
• Misra NC, Nigam PK, Gupta R, Agarwal AK, Kamboj VP.
  Centchroman--a non-steroidal anti-cancer agent for advanced breast cancer: phase-II study.
  Int J Cancer. 1989 May 15;43(5):781-3. 

1988

• Lal K, Sharma I, Agarwal AK, Agnihotri A, Ray S.
  C-nor-9,11-secoestranes as modified estrogens and fertility regulation.
  J Med Chem. 1988 Jun;31(6):1261-4. 

1987

• Ray S, Singh MM, Agarwal AK, Kamboj VP.
  Enhanced antifertility activity of non-steroidal molecules with 3-n-butylamino-2-hydroxypropyloxy side chain.
  Contraception. 1987 Mar;35(3):283-7.
• Singh AK, Lal K, Gupta DP, Agarwal AK, Ray S.
  Facile formation of hexahydro-4-(tetra-hydro-2-naphthalenyl)-2H-cyclopenta(b) furans from 9,11- secoestranes and its effect on estrogenicity.
  Ind J Chem 1987; 26B:839-842.

1986

• Salman M, Ray S, Anand N, Agarwal AK, Singh MM, Setty BS, Kamboj VP.
  Studies in antifertility agents. 50. Stereoselective binding of d- and l-centchromans to estrogen receptors and their antifertility activity.
  J Med Chem. 1986 Sep;29(9):1801-3.
• Jhingran AG, Gupta RC, Ray S, Agarwal AK, Singh MM, Anand N.
  Relative binding affinity and anti-implantation activity of 2,6?-diethyl-3-(2-methyl-4-hydroxyphenyl) bicyclo (4.3.0)
  non-2-7?-ol.
  Ind J Chem 1986; 25B:661-662.

1985

• Kamal N, Agarwal AK, Jehan Q, Setty BS. 
  Biological action of estrogen on the epididymis of prepubertal rhesus monkey.
  Andrologia. 1985 Jul-Aug;17(4):339-45. 

1983

• Salman M, Ray S, Agarwal AK, Durani S, Setty BS, Kamboj VP, Anand N. 
  Antifertility agents. 38. Effect of the side chain and its position on the activity of 3,4-diarylchromans.
  J Med Chem. 1983 Apr;26(4):592-5.
• Thingran AG, Gupta RC, Ray S, Agarwal AK, Singh MM, Anand N.
  Studies in antifertility agents--Part XLI : Secosteroids--X : Syntheses of various stereoisomers of ( /-) 2,6 beta -diethyl-7 alpha -ethynyl-3-(p-hydroxyphenyl)-trans-bicyclo[4.3.0]nonan-7 beta-ol.
  Steroids. 1983 Dec;42(6):627-34. 

1982

• Agarwal AK, Durani S, Setty BS.
  Dose dependent modulation of receptor dynamics and uterine growth in immature rat by estradiol: importance of an additional nuclear binding at 24 hr for long-term (72 hr) uterine growth.
  Endokrinologie. 1982 Jun;79(2):235-41. 

1980

• Gupta RC, Durani S, Agarwal AK, Kamboj VP, Anand N.
  Studies in antifertility agents: XVIII, Seco-steroids VIII: 2 , 6? Diethyl-3? (p-hydroxyphenyl)-trans-bicyclo (4.3.0) nonan-7?-ol and 6?-Methyl-3?-(p-hydroxyphenyl)-2 -propyl-trans-bicyclo (4.3.0) nonan-7?-ol.
  Ind J Chem 1980; 19B:886-890.

1979

• Durani S, Agarwal AK, Saxena R, Setty BS, Gupta RC, Kole PL, Ray S, Anand N.
  Secoestradiol and non-steroidal estrogens: structural correlates of estrogenic action. 
  J  Steroid Biochem 1979; 11:67-77.

1978

• Durani S, Agarwal AK, Ray S, Setty BS.
  Estrogen receptor: a correlation between structure and relative binding affinity of a series of chromans and chromenes, possessing post-coital contraceptive activity.
  J Steroid Biochem 1978; 9:838.